6th POLAND PHARMACOMMERCE FORUM

From visionaries to accurately developing strategies!

24-25 June 2015Hotel Courtyard by Marriott, Warsaw

Let us meet together to get ready today for tomorrow, especially as: ”The Future of Industry is Here”!

The Polish pharmaceutical sector has been subject to constant changes, turbulence and challenges presenting innumerable chances and opportunities.Despite all the challenges, changing environment and lack of support in many cases, we have to move forward. We must meet our goals and win even if we encounter difficulties, bumps, ruts and wind storms.

It is a real challenge to get ready for all the legal changes, future business models determining market trends, ever growing expectations both by Patients, HCP, Payers and new technologies. Therefore, the biggest issue presently is to make companies prepared for the future. We must all anticipate the future pharmaceutical market business model in order to best suit path breaking tactics, strategies and innovative solutions for tomorrow. The quicker we adapt and innovative the success will be quicker.

Precisely selected, well-thought over and implemented strategies and sets of tactics “make the difference”!

That is exactly why CEOs and Directors from leading pharmaceutical companies choose to share their valued thoughts, visions, as well as proven solutions during the Forum. You can then translate these inspirational thoughts into your own business-growth-oriented strategies.

Push ahead, against all odds!

THE POLISH PHARMACEUTICAL SECTOR HAS BEEN SUBJECT TO CONSTANT CHANGES, TURBULENCE AND CHALLENGES PRESENTING INNUMERABLE CHANCES AND OPPORTUNITIES.

Novelties in the 2015 editionEven more interactive formula – we build uniquecollective intelligence

Inspirations from outside the industry – we learn from the experiencesof the leaders of other sectors

„Table” groups – we discuss the biggest challenges of individual groupsof market participants

MasterClass Excellence Workshops – we present ready to be implementedknowledge and inspirations in the thematic areas you are most interested in

Collective Intelligence Closed Door Session – we talk about the key challenges and issues in a professional closed formula

12345

Inspirators for 2015

Andrzej KomorCustomer FacingExcellence Lead CNS Europe, Global CFEStartegy & OperationsUCB PHARMA BELGIA

Katarzyna Kuśmierz President and Chairpersonof the Supervisory BoardUSP ZDROWIE

Ireneusz MartyniukPresident of theManagement BoardPOLPHARMA SALES OFFICEVice-President of the Management BoardPOLPHARMA GROUP

Marcin MajchrzakVice-PresidentPOLSKA GRUPAFARMACEUTYCZNA

Izabela ZimmermannCEO and Vice-Presidentof the Management BoardACTAVIS POLSKA

Krzysztof KozikCEONOVO NORDISK PHARMA

SPECIAL GUEST: Rafał Sonikthe first Pole who won individually the legendaryDakar Rally,President ofGEMINI GROUP

SPECIAL GUEST: Anna JakubowskaCEOCOCA-COLAPOLAND SERVICES

Artur KrzyżanowskiNational SalesManagerNUTRICIA

dr n. med. Dorota Hryniewiecka-FirlejPresident of the Management Board and Director of the Global Innovative Pharma Business DepartmentPFIZER POLSKA

Michał NitkaCEOCentral&Eastern EuropeTEVA

Maciej ChmielowskiGeneral ManagerPoland and BalticCountriesFRESENIUS KABI

SPECIAL GUEST: Przemysław GostkiewiczMember of the Board, Sales Director DANONE

Mariusz BorkowskiBusiness Unit ManagerADAMED

Piotr JakubczakSenior ConsultantIMS HEALTH

Kazimierz MurzynChairman of the Boardand CEOKLASTER LIFESCIENCE

www.pharma-conferences.com/ppcf/prelegenci

Andrzej KomorCustomer FacingExcellence Lead CNS Europe, Global CFEStartegy & OperationsUCB PHARMA BELGIA

Mikołaj PiaskowskiCounsel, Headof CompetitionLaw PracticeBAKER & McKENZIEKRZYŻOWSKI I WSPÓLNICY

Ireneusz MartyniukPresident of theManagement BoardPOLPHARMA SALES OFFICEVice-President of the Management BoardPOLPHARMA GROUP

Andrzej StachnikPresidentTHE EMPLOYERS’ UNION OF PHARMACEUTICAL WHOLESALERS

Irena RejPresident“FARMACJA POLSKA”CHAMBER OF COMMERCE

dr n. med. Dorota Hryniewiecka-FirlejPresident of the Management Board and Director of the Global Innovative Pharma Business DepartmentPFIZER POLSKA

dr hab. Marek ŚwierczyńskiAttorney-at-lawBAKER & McKENZIEKRZYŻOWSKI I WSPÓLNICY

Stefan BogusławskiManaging Partner, President of the Management BoardSEQUENCE HC PARTNERS

Ewa Tomala-ŻelechowskaStrategy & Business Development DirectorQAH

Michał WieczorekMember Of The BoardADAMEDADAMED CONSUMERHEALTHCARE

Anetta SienkiewiczCEOMARKET CONSULTING

Łucja GdalaManaging DirectorCODEMEDIA

Piotr BieńkoCEOCODEMEDIA

Artur SchabManaging PartnerR PHARMACEUTICAL CONSULTING

Zdzisław J. SabiłłoCEO PHARMA BUSINESSADMINISTRATIONCONSULTANCY

AgnieszkaWolańska-KoneckaCEOWILL TO CHANGE

Radosław ChomiukEditor in ChiefPHARMACEUTICALREPRESENTATIVE

Agenda, 24 June, day one 8:30 Registration and morning coffee 9:00 Inspiring the Forum and networking session Aleksandra Schoen-Żmijowa, Project Director, Blue Business Media

9:20 Winning in spite of the strong headwind – during the Dakar rally and in business activities Rafał Sonik, the first Polish national who won the legendary Dakar Rally individually, CEO, Grupa Gemini 9:55 Q&A Session

THE FUTURE OF THE INDUSTRY IS HERE - BE PREPARED!

10:05 OPENING PANEL: Pharma 2015 vs. 2025 what will the future bring? Successful long-term business management in a changing commercial business Dorota Hryniewiecka-Firlej, President of the Board, Pfizer Krzysztof Kozik, President of the Board, NovoNordisk Pharma Ireneusz Martyniuk, CEO, Polpharma Biuro Handlowe, Deputy CEO, Polpharma Group Michał Nitka, General Manager Central & Eastern Europe, Teva The way commercial models have evolved over the recent years – observations on the future development directions The points of view by CEOs concerning trends and sector changes eHealth revolution Which of the medical trends will find their reflections in the pharmaceutical sector? What are the expectations of CEOs from their commercial departments? – the sales and marketing departments – anticipating changes and preparing for changes Looking into the future of the industry, supported by the experience of all the meeting participants10:45 Evolution or revolution – the way the Polish pharmaceutical market will change Ireneusz Martyniuk, CEO, Polpharma Biuro Handlowe, Deputy CEO, Polpharma Group Key development indicators, which all point to the direction of changes, their dynamics and character (durability, significance, multi-dimensional character) European pharmaceutical market models, as indicators of the potential development direction for the Polish drug market Dilemmas of the Polish pharmaceutical industry managers11:05 3 question session – only 3 chances to ask a question, all the remaining questions to be asked outside the session11:10 The future of the CONSUMER HEALTH industry Katarzyna Kuśmierz, Director General, USP ZDROWIE Where is our industry heading? World trends Consumers in the focal point of our attention Our industry responsibility for consumer communication and education11:30 3 question session11:35 Coffee break, unofficial conversations and mini-fair Innovation Fair I: New solutions supporting the pharmaceutical sector. Please, visit our stands in the lobby. Let us surprise you!11:55 Eliminating the risk in the pharmaceutical market Dorota Hryniewiecka-Firlej, President of the Board, Pfizer Methods, techniques and tools to determine the risk affecting the pharmaceutical market Factors which influence the amount of the pharmaceutical market risk (on the example of an innovative drug commercialisation process) Assessing the possibility to influence the variables determining the pharmaceutical market risk12:15 3 question session12:20 How rising patient expectations impact into business of manufacturer ,pharmacy and distributor Marcin Majchrzak, Vice President, PGF12:45 Lunch13:45 The future of drug reimbursement and price models – an analysis of price models evolutions in other countries – where is the Polish market going to be in a few years? Stefan Bogusławski, CEO, Sequence HC Partners Drug reimbursement is not and is not going to be invested in by the public payer The cost efficiency assessment of new therapies on the funding system level is going to gain significance There is a need to develop new funding mechanisms – RSS and third party payers

14:15 3 question session

14:20 Future legal regulations – what legal changes should we expect next year, in the next five or ten years. Where are we heading?

Marek Świerczyński PhD., Attorney, Baker & McKenzie Krzyżowski i Wspólnicy Wiktor Krzymowski, Lawyer, Baker & McKenzie Krzyżowski i Wspólnicy14:40 3 question session14:45 Future of Talents in the company- how to keep the best

Anna Pfejfer-Buczek, Managing Partner, Oprandi15:00 3 question session15:05 Inspiration of Partner of Forum ! How to adapt infrastructure to the needs of a growing organization - optimization of the cost of renting commercial space

Joanna Blumert, Business Development Manager, Office Department, Cushman&Wakefield15:20 3 question session

INTERACTIVE WRAP-UP SESSION “THE FUTURE OF THE INDUSTRY IS HERE – BE PREPARED!”

15:25 Please, join our “table” group discussions – the most serious challenges in front of given groups of market players:

• Legal Challenges- theory and practice

Irena Rej, President, Chamber of Commerce Pharma Poland

• Challenges for distribution companies Andrzej Stachnik, President, ZPHF

• Innovation in the field of life science Kazimierz Murzyn, Chairman of the Board and CEO, LifeScience Cluster

• Challenges for pharmaceutical companies (innovative and generic) Zdzislaw J. Sabiłło, President, Pharma Business Administration Consultancy16:00 Inspiration! – Remarks and summing-up from each of the groups16:15 Coffee break and selecting a workshop

MINI-WORKSHOPS: MASTER CLASS EXCELLENCE WORKSHOPS

Please, join our mini-workshop sessions – to discuss issues in smaller groups. The sessions aim at gathering ready-to-use and ready-to-implement knowledge, as well as inspiration in the areas our participants find the most interesting. There will be two rounds of meetings.

16:30 Mini-workshop – interactive master class – round I Suggested areas for discussion:

1. Real World Evidence

Piotr Jakubczak, Senior Consultant, IMS Health

2. Multichannel - Be digital or die: access to HCP and Patients by efficient e-marketing tools

Łucja Gdala, Managing Director, Codemedia

3. We will win thanks to our talents! Attracting them, retaining them, spoiling them

Agnieszka Wolańska-Konecka, Prezes Zarządu, Will To Change

4. Manners of collaboration with pharmacy chains in order to boost our sales excellence

Artur Schab, Managing Partner, R Pharmaceutical Consulting

17:10 Break to switch to another workshop session

17:15 Mini-workshop – interactive master class – round II17:55 Networking cocktail19:30 The end of the first day of the Forum

Agenda, 25 June, day two

8:30 Registration and morning coffee

STRATEGIC SALES & MARKETING EXCELLENCE

9:00 Pharma vs. Patient – new collaboration perspectives: generating the added value – new challenges, new services, new capabilities Maciej Chmielowski, General Manager Poland and Baltic Countries, Fresenius Kabi The influence of the hospital market evolution on new perspectives of Patient collaboration “Hospital at home” – new capabilities of assisting the Patient The role of patient associations and organisations in the market development 9:20 Interactive Q&A session 9:30 Pharma against a new sales model – Is it time for change? Case study UCB Andrzej Komor, Customer Facing Excellence Lead CNS Europe, Global CFE Startegy & Operations, UCB Pharma Belgia Product Based Selling Model – is it still working? Digital-era customers – their changing expectations What sales representatives does Pharma need today? 9:55 Interactive Q&A session10:05 Sales Excellence of the future – with representatives or… with their avatars? Case study Nutricia Artur Krzyżanowski, National Sales Manager, Nutricia, “Senior Marketer No-UK of the year 2013” Meeting the needs of a contemporary client Innovative way of thinking to make yourself distinguishable and start long-term relations with your clients The new role of the Key Account Manager (KAM) – the customer in the centre of everyone’s attention10:30 Interactive Q&A session10:40 Note inspiration ! AD- HERENCE innovative design of monitoring treatment of patients with chronic diseases Anetta Sienkiewicz, CEO, Market Consulting The innovative device to monitor the use of drugs by patients with chronic diseases ICT infrastructure for collecting data Applications for patients and physicians10:50 Coffee break, unofficial discussions and mini-fair Innovation Fair I: New solutions supporting the pharmaceutical sector. Please, visit our stands in the lobby. Let us surprise you!11:10 Pharma-marketing 360 degrees. The multi-channel world dimensions of the pharmaceutical market Ewa Tomala-Żelechowska, Strategy & Business Development Director, QAH 360 degrees by decision makers in the doctor – pharmacist – patient market 360 degrees of each product 360 degrees as a full integration of all communication channels11:30 Interactive Q&A session11:35 New omni-channel communication model: the true face of the integrated communication – synergy, complementing, permeating Piotr Bienko, CEO, Codemedia Łucja Gdala, Managing Director, Codemedia11:55 Interactive Q&A session12:00 Lunch13:00 Customer Insight – Coping with a new generation of consumers whose 85% of purchasing decisions are driven by emotions Special Guest: Anna Jakubowska, Director General for Poland and Baltic States, Coca-Cola Poland Services13:30 Interactive Q&A session13:40 Leading to your sales team motivation and engagement is like the “Holy Grail” not only in the pharma sector – FMCG inspirations Special Guest: Przemysław Gostkiewicz, Member of the Board, Sales Director, Danone14:10 Interactive Q&A session

INTERACTIVE LEGAL SESSION

14:20 Contemporary distribution models vs. the competition law Mikołaj Piaskowski, Counsel, Legal Advisor, Head of the Competition Protection Practice,

Baker & McKenzie Krzyżowski i Wspólnicy

14:40 Interactive Q&A session

14:50 Coffee break

COLLECTIVE INTELLIGENCE CLOSED DOOR SESSION

15:00 In order to wrap up the forum and leave all the participants to the forum with this spirit of mutual exchange of experience and inspirations, the participants will be divided into some different subject matter groups. Each “round table” will have 35 minutes to discuss the subject matter: 5 minutes of an introductory presentation by the “group moderator” and 30 minutes for the discussion. At the end the Moderator will sum up the table discussion discoveries. Planned areas of discussion:

Innovative Methods for Cooperation with pharmacies

Anetta Sienkiewicz, CEO, Market Consulting Branded vs. Generix INN - International Nonproprietary Names - what could it mean in practice for the market

Zdzisław J. Sabiłło, President, Pharma Business Administration Consultancy The traditional model of selling vs Key Account Management - organizational restructuring

Radosław Chomiuk, Editor in Chief, Pharmaceutical Representative

15:35 Summing up of table discussions15:50 The end of the Forum and certificates

Current agenda of the Forum available at: www.pharma-conferences.com/ppcf/program

If you are interested in joining the agendaplease contact:

Aleksandra Schoen-Żmijowa / Project Directortel. +48 12 350 54 24e-mail: aleksandra.schoen@bbm.pl

Poland PharmaCommerce Forum2015:

AS PART OF

More information about previous editions: www.pharma-conferences.com/ppcf/relacje

We organize a meeting for key decision-makersrepresenting the largest companies fromthe pharmaceutical industry, across divisions

We prepare the sector for tomorrow – we presentpredictions for the future, new trends, innovative tools and efficient solutions

We inspire Sector Leaders in the Master-Masterformula to improve and create unique tacticsand strategies guaranteeing business growth despite market changes

We talk about the future of the pharmaceuticalmarketing and sales communication as well asuse of innovation

We develop the formula of the event to even better adapt to participants’ expectations and increaseinteraction and exchange of experiences betweenthe gathered sector leaders

The cost of participation of one person at the Forum is:

REGISTRATIONof participation in the Forum

Detailed registration terms and on-line registration form available at the website:

www.pharma-conferences.com/zgloszenie

2995 PLN (+23% VAT) with registration by 15 May 2015

3495 PLN (+23% VAT) with registration in the period 16 May – 5 June 2015

3995 PLN (+23% VAT) with registration after 5 June 2015

ABOUT COOPERATIONAnna Chrobot B4B Communications Manager anna.chrobot@bbm.pl+48 22 256 70 35

ABOUT REGISTRATIONAnna Banaś Head of Sales anna.banas@bbm.pl+48 12 350 54 06

Blue Business Media Sp. z o.o. Oddział Krakówul. Berka Joselewicza 21c, 31-031 Krakówtel. + 48 12 35 05 400, fax. + 48 12 35 05 401info@bbm.pl, www.bbm.pl

PATRON MEDIALNY:

PATRONI:

ORGANIZATOR:

PARTNERZY: